VOYA Investment Management
RCKT icon

VOYA Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History

VOYA Investment Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.5K Buy
18,558
+3,908
+27% +$13K ﹤0.01% 2413
2026
Q1 		$52.4K Hold
14,650
– – ﹤0.01% 2271
2025
Q4 		$51.4K Hold
14,650
– – ﹤0.01% 2339
2025
Q3 		$47.8K Sell
14,650
-7,858
-35% -$24.8K ﹤0.01% 2387
2025
Q2 		$55.1K Buy
22,508
+3,151
+16% +$16K ﹤0.01% 2586
2025
Q1 		$129K Sell
19,357
-618
-3% -$6.11K ﹤0.01% 2372
2024
Q4 		$251K Sell
19,975
-1,493
-7% -$22.5K ﹤0.01% 2284
2024
Q3 		$397K Sell
21,468
-379
-2% -$7.76K ﹤0.01% 2127
2024
Q2 		$470K Buy
21,847
+1,191
+6% +$27.4K ﹤0.01% 2043
2024
Q1 		$556K Sell
20,656
-3,828
-16% -$109K ﹤0.01% 1960
2023
Q4 		$734K Buy
24,484
+2,037
+9% +$45K ﹤0.01% 1865
2023
Q3 		$460K Buy
22,447
+229
+1% +$4.16K ﹤0.01% 2082
2023
Q2 		$441K Buy
22,218
+1,674
+8% +$33.8K ﹤0.01% 2149
2023
Q1 		$352K Sell
20,544
-9,723
-32% -$190K ﹤0.01% 2240
2022
Q4 		$592K Sell
30,267
-10,088
-25% -$186K ﹤0.01% 1934
2022
Q3 		$644K Buy
40,355
+20,167
+100% +$315K ﹤0.01% 1868
2022
Q2 		$278K Buy
20,188
+4,297
+27% +$51.2K ﹤0.01% 2219
2022
Q1 		$252K Hold
15,891
– – ﹤0.01% 2254
2021
Q4 		$347K Sell
15,891
-247,467
-94% -$6.75M ﹤0.01% 2219
2021
Q3 		$7.87M Sell
263,358
-15,594
-6% -$568K 0.02% 671
2021
Q2 		$12.4M Buy
278,952
+130,707
+88% +$5.68M 0.02% 526
2021
Q1 		$6.58M Sell
148,245
-20,283
-12% -$1.11M 0.01% 743
2020
Q4 		$9.24M Sell
168,528
-42,155
-20% -$1.54M 0.02% 607
2020
Q3 		$4.82M Buy
210,683
+14,712
+8% +$363K 0.01% 764
2020
Q2 		$4.1M Sell
195,971
-79,329
-29% -$1.43M 0.01% 813
2020
Q1 		$3.84M Buy
275,300
+145,364
+112% +$2.88M 0.01% 769
2019
Q4 		$2.96M Buy
129,936
+119,260
+1,117% +$1.99M 0.01% 963
2019
Q3 		$124K Hold
10,676
– – ﹤0.01% 2358
2019
Q2 		$160K Buy
+10,676
New +$186K ﹤0.01% 2360

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

VOYA Investment Management's RCKT Position: Q2 2026 in Review

VOYA Investment Management increased its Rocket Pharmaceuticals (RCKT) stake by 27% in Q2 2026, buying an estimated $13K and bringing the position to 18,558 shares worth $63.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2413.

VOYA Investment Management first reported a position in RCKT in Q2 2019 and has held it in 29 quarters since. The position peaked at $12.4M in Q2 2021. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • VOYA Investment Management held 18,558 shares of Rocket Pharmaceuticals worth $63.5K as of Q2 2026.
  • VOYA Investment Management bought 3,908 Rocket Pharmaceuticals shares in Q2 2026, an estimated $13K.
  • Rocket Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2413 holding.
  • VOYA Investment Management first reported a position in Rocket Pharmaceuticals in Q2 2019 and has held it in 29 quarters since.
  • VOYA Investment Management's Rocket Pharmaceuticals position peaked at $12.4M in Q2 2021.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.